Pulmonary Fibrosis Foundation
Amy Wardzala has a diverse work experience that began in 2010 with a role as a Marketing & Event Coordinator at BNP Media. In this position, they played a key role in securing exhibitors, contributing to increased attendance and revenue for multiple events. Amy then worked at the Cystic Fibrosis Foundation as a Logistics Coordinator and later as a Development Manager, where they managed communications, donor cultivation, and event logistics. Amy also served as an Event Manager at the Illinois Network of Charter Schools before joining CorePower Yoga as a Yoga Instructor. Amy'swork at CorePower Yoga involved instructing classes and providing exceptional customer experiences. Currently, Amy holds the title of Vice President, Development at the Pulmonary Fibrosis Foundation, where they oversee fundraising efforts and special events.
Amy Wardzala attended Illinois State University from 2006 to 2010, where they earned a Bachelor of Science degree in Communication. During their time at university, they focused on the fields of Public Relations and Writing. In 2008, Amy also briefly studied at Lorenzo de' Medici for International & Intercultural Communication.
Pulmonary Fibrosis Foundation
We imagine a world without pulmonary fibrosis. The Pulmonary Fibrosis Foundation is focused on our mission to act as the trusted resource for all who are affected by this disease. Our signature programs include: PFF Care Center Network PFF Patient Registry PFF Patient Communication Center PFF Ambassador Program An international network of support groups and online communities The PFF Summit Comprehensive disease education materials Our expert Medical Advisory Board and the biennial PFF Summit allow us to maintain an ongoing dialogue with physicians, researchers, industry representatives, and the patient community. This creates a collaborative environment that will help us achieve many of our goals. Our peer-reviewed research program supports projects that improve understanding of pulmonary fibrosis and will lead to successful therapies. We have developed significant relationships with industry partners and upheld our position as the honest broker to inform those affected by pulmonary fibrosis of important scientific breakthroughs.